Product Overview

Type:                         COVID-19 Vaccine (ChAdOx1-S ([recombinant])

INN:                           N/A

Trade name:             Vaxzevria

EUL holder:               AstraZeneca AB

Country:                    Sweden

Responsible NRA:     National Administration of Medicines, Food and Medical Technology (ANMAT)

Country:                     Argentina


WHO EUL Recommendation

Effective date:            23 December 2021


Product description

Pharmaceutical Form:                   Suspension for injection                                    

Presentation:                                   6 mL vial

Number of doses:                            10 doses (0.5 mL per dose)

Route of administration:                Intramuscular

Age indication:                                18 years and older

Shelf – life:                                       6 months     Storage temperature:   2°C to 8°C      

Vaccine Vial monitor (VVM):        None

Preservative:                                    None

Adjuvant:                                           None

Diluent:                                               None

Handling of opened multi-dose vials: 

WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.


Packaging description

Secondary Packaging: 

 a. Carton of ten vials (100 doses). Dimensions: 13.9 x 5.4 x 6.1 cm

Tertiary Packaging: 

 a. 24 secondary packaged cartons (1240 vials/2400 doses). Dimensions: 28.5 x 23.3 x 19.9 cm

Cold Chain Volume in

secondary packaging:

 a. 4.6 cm3/dose


Product Characteristics and Package Leaflet